SY

Suvarchala Yerramilli

Active Director Director DIN 01305720
DIN 01305720 First appointment Aug 2005 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 4 active board seats
Past companies 8 historical roles
Total affiliations 12 Since Aug 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Suvarchala Yerramilli

Data last updated:

Suvarchala Yerramilli is a Director at Endoven Pharmaceuticals Private Limited (since 2009), Director at Legend Drugs And Formulations Private Limited (since 2008) and Director at Shruthi Infraprojects Private Limited (since 2008), and holds 1 more current directorship. The companies operate in Pharma, Construction and Real Estate and Construction. Earlier, Suvarchala Yerramilli was a Director at K.R.Business Services Private Limited (2007–2009) and Director at Leela Infracon Private Limited (2008–2010) and 6 more.

DIN 01305720
Primary Designation Director
Industry Pharma
First Appointment 25 Aug 2005
Oldest Company Age 33 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 20091998Active
Director01 Apr 20081993Active
Director19 Feb 20082008Active
Director25 Aug 20052005Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jun 20072007Strike Off
Leela Infracon Private Limited U45202MH2008PTC179090
Director19 Feb 20082008Strike Off
Gopal Mercandise Private Limited U51109MH2008PTC179757
Director05 Mar 20082008₹16,447 (FY 2025)Active
Leela Drugs Private Limited U24100MH2011PTC219001
Director23 Jun 20112011Strike Off
Maitri Bio-Chem Private Limited U24230MH2004PTC148268
Director29 Sep 20092004Strike Off
Leela Lifescience Private Limited U24239MH2008PTC179756
Director05 Mar 20082008Strike Off
Leela Arcades Private Limited U45205MH2007PTC174849
Director09 Oct 20072007Strike Off
Leela Infraventure Private Limited U74999MH2008PTC178992
Director18 Feb 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Leela Drugs Private Limited
Legend Drugs And Formulations Private Limited
Endoven Pharmaceuticals Private Limited
Maitri Bio-Chem Private Limited
Premium access

Shareholding and investment profile for Suvarchala Yerramilli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suvarchala Yerramilli

Suvarchala Yerramilli currently holds 4 directorships: Endoven Pharmaceuticals Private Limited (Director, since 01 Apr 2009); Legend Drugs And Formulations Private Limited (Director, since 01 Apr 2008); Shruthi Infraprojects Private Limited (Director, since 19 Feb 2008); Leela Ventures (India) Private Limited (Director, since 25 Aug 2005).

Suvarchala Yerramilli was first appointed on 25 Aug 2005 as Director at Leela Ventures (India) Private Limited. The most recent appointment on record is 23 Jun 2011 at Leela Drugs Private Limited.

Suvarchala Yerramilli held 8 earlier board appointments: K.R.Business Services Private Limited (Director, 30 Jun 2007 to 16 Mar 2009); Leela Infracon Private Limited (Director, 19 Feb 2008 to 19 Jul 2010); Gopal Mercandise Private Limited (Director, 05 Mar 2008 to 12 Jan 2015); Leela Drugs Private Limited (Director, from 23 Jun 2011); Maitri Bio-Chem Private Limited (Director, from 29 Sep 2009); and 3 more.

The current boards of Suvarchala Yerramilli's companies include Yerramilli Venkata Surya Sanyasi Raju (Endoven Pharmaceuticals Private Limited), Ketan Dahyalal Pandya (Legend Drugs And Formulations Private Limited), Bhupendra Abhimanyu Kukreja (Shruthi Infraprojects Private Limited), Sanjay Kukreja Cheturam (Shruthi Infraprojects Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available